FSWFX | HGXCX | FSWFX / HGXCX | |
Total Expense Ratio | 0.76 | 1.94 | 39% |
Annual Report Gross Expense Ratio | 0.76 | 1.99 | 38% |
Fund Existence | 5 years | 8 years | - |
Gain YTD | 9.782 | 11.505 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 80.3B | 312M | 25,737% |
Annual Yield % from dividends | 0.85 | 0.00 | - |
Returns for 1 year | 9.10 | 11.06 | 82% |
Returns for 3 years | 26.52 | 27.64 | 96% |
Returns for 5 years | N/A | 34.87 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FISEX | 34.32 | 0.02 | +0.06% |
Franklin Equity Income A | |||
NSOPX | 17.40 | -0.10 | -0.57% |
North Star Opportunity A | |||
GGZPX | 23.91 | -0.14 | -0.58% |
Goldman Sachs Enhanced U.S. Equity P | |||
RICBX | 64.09 | -0.46 | -0.71% |
American Funds Invmt Co of Amer R2 | |||
ETAHX | 36.37 | -0.50 | -1.36% |
Eventide Healthcare & Life Sciences A |